Armistice Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-66,169
Closed -$21.5M 405
2024
Q1
$21.5M Sell
66,169
-359,888
-84% -$88.4M 0.29% 66
2023
Q4
$81.2M Buy
426,057
+267,055
+168% +$50.5M 1.11% 10
2023
Q3
$31.7M Buy
159,002
+9,002
+6% +$2.13M 0.48% 41
2023
Q2
$42.8M Sell
150,000
-106,000
-41% -$29.4M 0.62% 37
2023
Q1
$55.5M Buy
256,000
+204,000
+392% +$39.7M 0.8% 28
2022
Q4
$10.7M Buy
52,000
+16,000
+44% +$4.05M 0.19% 72
2022
Q3
$10M Buy
+36,000
New +$9.15M 0.17% 74

Other funds holding SWAV

Armistice Capital's SWAV Position: Q2 2024 in Review

Armistice Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 66,169 shares — an estimated $21.5M sold.

Armistice Capital first reported a position in SWAV in Q3 2022 and held it in 7 quarters. The position peaked at $81.2M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Armistice Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Armistice Capital sold 66,169 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $21.5M.
  • Armistice Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Armistice Capital's Shockwave Medical, Inc. Common Stock position peaked at $81.2M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.